Simplex Trading’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Simplex Trading’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,100	Closed	-$15K	–	10177
2023 Q4	$15K	Buy	2,100 +1,544	+278%	+$17.1K	﹤0.01%	7163
2023 Q3	$10K	Buy	556 +339	+156%	+$8.25K	﹤0.01%	7209
2023 Q2	$6K	Buy	+217	New	+$8.66K	﹤0.01%	7862
2023 Q1	–	Sell	-217	Closed	-$5K	–	10396
2022 Q4	$5K	Buy	+217	New	+$5.9K	﹤0.01%	8126
2022 Q3	–	Sell	-106	Closed	-$3K	–	11118
2022 Q2	$3K	Buy	+106	New	+$7.32K	﹤0.01%	9231

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $173M AUM 14.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Simplex Trading's TBIO Position: Q2 2024 in Review

Simplex Trading sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 6 shares.

Simplex Trading first reported a position in TBIO in Q2 2022 and held it in 7 quarters. The position peaked at $17K in Q1 2023. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

Simplex Trading reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 6 Telesis Bio, Inc. Common Stock shares in Q2 2024.
Simplex Trading first reported a position in Telesis Bio, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
Simplex Trading's Telesis Bio, Inc. Common Stock position peaked at $17K in Q1 2023.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.